The role of Smad3 in mediating mouse hepatic stellate cell activation

Hepatology

Volumn 34, Issue 1, 2001, Pages 89-100

  Schnabl, Bernd ^a   Kweon, Young O ^a   Frederick, Joshua P ^b   Wang, Xiao Fan ^b   Rippe, Richard A ^a   Brenner, David A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1ALPHA; COLLAGEN TYPE 2ALPHA; DNA; MESSENGER RNA; SMAD PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA BINDING; IN VIVO STUDY; KNOCKOUT MOUSE; LIVER CELL; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL;

EID: 0034956559     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.25349     Document Type: Article

References (74)

1. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
2. Alcoholic liver injury in baboons: Transformation of lipocytes to transitional cells
3. Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver
4. Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells
5. Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat. Immunoelectron microscopic observation of type I, type III collagens, and prolyl hydroxylase
6. The effects of hepatic fibrosis on Ito cell gene expression
7. Isoforms and splice variant of transforming growth factor beta-binding protein in rat hepatic stellate cells
8. Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo
9. Ito-cell gene expression and collagen regulation
10. Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells
11. Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells
12. Transforming growth factor beta responsiveness is modulated by the extracellular collagen matrix during hepatic Ito cell culture
13. Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta
14. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: Regulation by TNF-alpha and TGF-beta1
15. Transforming growth factor beta 1-regulated gene expression of Ito cells
16. Transforming growth factor-beta in disease: The dark side of tissue repair
17. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy
18. Increased transforming growth factor-beta 1 gene expression in human liver disease
19. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis
20. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis
21. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation
22. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions
23. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice
24. TGF-beta1 in liver fibrosis: An inducible transgenic mouse model to study liver fibrogenesis
25. Mechanism of activation of the TGF-beta receptor
26. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling
27. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways
28. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4
29. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4
30. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
31. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein
32. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling
33. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling
34. Smad6 inhibits signalling by the TGF-beta superfamily
35. Transcriptional control by the TGF-beta/Smad signaling system
36. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction
37. Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells
38. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling
39. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils
40. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo
41. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction
42. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
43. Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells
44. Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells
45. Minimal DNA sequences that control the cell lineage-specific expression of the pro alpha 2(I) collagen promoter in transgenic mice
46. In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: Evidence for predominant expression in nonparenchymal liver cells
47. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
48. In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia
49. Involution of mouse mammary glands in whole organ culture: A model for studying programmed cell death
50. Sp1 binding activity increases in activated Ito cells
51. Human Smad3 and Smad4 are sequence-specific transcription activators
52. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta
53. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
54. Stimulation of the collagen alpha 1 (I) endogenous gene and transgene in carbon tetrachloride-induced hepatic fibrosis
55. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: Involvement of Smad 3
56. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta
57. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators
58. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway
59. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
60. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis
61. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts
62. Characterization of desmin-positive rat liver sinusoidal cells
63. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
64. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death
65. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta
66. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
67. Expression and secretion of type beta transforming growth factor by activated human macrophages
68. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels
69. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response
70. Smad2 role in mesoderm formation, left-right patterning and craniofacial development
71. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo
72. Smad3 mutant mice develop metastatic colorectal cancer
73. A transcriptional partner for MAD proteins in TGF-beta signalling
74. Smad4 and FAST-1 in the assembly of activin-responsive factor